Advertisement
Research Article

Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts

  • Tanja Stocks mail,

    tanja.stocks@urologi.umu.se

    Affiliation: Department of Surgical and Perioperative sciences, Urology and Andrology, Umeå University, Umeå, Sweden

    X
  • Kilian Rapp,

    Affiliation: Institute of Epidemiology, Ulm University, Ulm, Germany

    X
  • Tone Bjørge,

    Affiliations: Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway, Norwegian Institute of Public Health, Bergen, Norway

    X
  • Jonas Manjer,

    Affiliation: Department of Surgery, Malmö University Hospital, Malmö, Sweden

    X
  • Hanno Ulmer,

    Affiliation: Department of Medical Statistics, Informatics and Health Economics, Innsbruck Medical University, Innsbruck, Austria

    X
  • Randi Selmer,

    Affiliation: Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway

    X
  • Annekatrin Lukanova,

    Affiliation: Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany

    X
  • Dorthe Johansen,

    Affiliation: Department of Surgery, Malmö University Hospital, Malmö, Sweden

    X
  • Hans Concin,

    Affiliation: Agency for Preventive and Social Medicine, Bregenz, Austria

    X
  • Steinar Tretli,

    Affiliation: Institute of Population-based Cancer Research, The Cancer Registry of Norway, Oslo, Norway

    X
  • Göran Hallmans,

    Affiliation: Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden

    X
  • Håkan Jonsson,

    Affiliation: Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden

    X
  • Pär Stattin

    Affiliation: Department of Surgical and Perioperative sciences, Urology and Andrology, Umeå University, Umeå, Sweden

    X
  • Published: December 22, 2009
  • DOI: 10.1371/journal.pmed.1000201

About the Authors

Tanja Stocks, Pär Stattin
Department of Surgical and Perioperative sciences, Urology and Andrology, Umeå University, Umeå, Sweden
Kilian Rapp
Institute of Epidemiology, Ulm University, Ulm, Germany
Tone Bjørge
Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
Tone Bjørge
Norwegian Institute of Public Health, Bergen, Norway
Jonas Manjer, Dorthe Johansen
Department of Surgery, Malmö University Hospital, Malmö, Sweden
Hanno Ulmer
Department of Medical Statistics, Informatics and Health Economics, Innsbruck Medical University, Innsbruck, Austria
Randi Selmer
Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
Annekatrin Lukanova
Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany
Hans Concin
Agency for Preventive and Social Medicine, Bregenz, Austria
Steinar Tretli
Institute of Population-based Cancer Research, The Cancer Registry of Norway, Oslo, Norway
Göran Hallmans
Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden
Håkan Jonsson
Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden

Corresponding Author

Email: tanja.stocks@urologi.umu.se

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

ICMJE criteria for authorship read and met: TS KR TB JM HU RS AL DJ HC ST GH HJ PS. Agree with the manuscript's results and conclusions: TS KR TB JM HU RS AL DJ HC ST GH HJ PS. Designed the experiments/the study: TS TB JM HU PS. Analyzed the data: TS TB JM HU DJ HJ PS. Collected data/did experiments for the study: HC GH HJ. Enrolled participants: HC GH. Wrote the first draft of the paper: TS PS. Contributed to the writing of the paper: TS KR TB JM HU RS AL ST GH HJ PS. Responsible for integrity of the Norwegian data: RS. Responsible for the linkage and the quality of the dataset and for ensuring that the application of the data is correct: for Norwegian data, ST; for the full Me-Can cohort, TS, HJ. Principal investigator of the Me-Can project; designed and financed the Me-Can project as well as the specific study on glucose and cancer risk: PS.